Capmatinib in <i>MET</i> Exon 14–Mutated or <i>MET</i> -Amplified Non–Small-Cell Lung Cancer

Jürgen Wolf, Takashi Seto, Ji‐Youn Han, +29

New England Journal of Medicine

Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations

Tommaso De Pas, Francesca Toffalorio, Michela Manzotti, +8

Journal of Thoracic Oncology

MedicineReceptor Tyrosine KinasePathologyBronchial NeoplasmCancer Treatment +5

Capmatinib (INC280) in <i>METΔex14</i>-mutated advanced non-small cell lung cancer (NSCLC): Efficacy data from the phase II GEOMETRY mono-1 study.

Juergen Wolf, Takashi Seto, Ji‐Youn Han, +15

Journal of Clinical Oncology

Geometry Mono-1Met-amplified Advanced NsclcPathologyPharmacotherapyOncology +15

Large-Cell Neuroendocrine Carcinoma of the Lung Harboring<i>EGFR</i>Mutation and Responding to Gefitinib

Tommaso Martino De Pas, Monica Giovannini, Michela Manzotti, +6

Journal of Clinical Oncology

Large-cell Neuroendocrine CarcinomaEndocrine OncologyMedicineCancer Cell BiologyPathology +9

Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer

Annamaria Molino, Monica Giovannini, A. Auriemma, +7

Critical Reviews in Oncology/Hematology

Surgical OncologyBreast OncologyGeriatricsMedicineElderly Women +9

Phase 1 study of capmatinib in MET‐positive solid tumor patients: Dose escalation and expansion of selected cohorts

Yung‐Jue Bang, Wu‐Chou Su, Martin Schüler, +12

Cancer Science

Phase (Ph) I study of the safety and efficacy of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced cMET+ non-small cell lung cancer (NSCLC).

Martin Schüler, Rossana Berardi, Wan‐Teck Lim, +17

Journal of Clinical Oncology

Pre-clinical PharmacologyOncologyNsclc GroupsMedicinePathology +12

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies

Monica Giovannini, Vanesa Gregorc, Carmen Belli, +5

Journal of Oncology

Tumor BiologySkin CancerMedicineCutaneous BiologySkin Reaction +9

Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors

Víctor Moreno, Richard Greil, Jeffrey Yachnin, +8

Clinical Therapeutics

MSH2 and MLH1 immunodetection and the prognosis of colon cancer

J Perrin, Joanny Gouvernet, D. Parriaux, +6

International Journal of Oncology

Gastrointestinal OncologyMedicineGeneticsImmunologyPathology +13